gentuximab
/ GeneScience
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 26, 2023
Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.
(clinicaltrials.gov)
- P3 | N=752 | Recruiting | Sponsor: GeneScience Pharmaceuticals Co., Ltd.
Metastases • New P3 trial • Esophageal Cancer • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1